Tinghao Yan
Jinan, 250000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Extrachromosomal DNA (ecDNA) drives hepatocellular carcinoma malignancy through high-copy amplification of chromosome 1q21-derived PIP5K1A oncogene.
Journal: Cancer letters
Published: June 12, 2025
Mechanistic Exploration of Shugan Jianpi Formula for Treating Triple-Negative Breast Cancer Under Chronic Stress: A Network Pharmacology-Guided Experimental Study.
Journal: Drug design, development and therapy
Published: February 10, 2025
Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential.
Journal: Frontiers in immunology
Published: February 08, 2025
PCK2 induces gefitinib resistance by suppresses ferroptosis in non-small cell lung cancer.
Journal: Biochemical and biophysical research communications
Published: April 02, 2024
Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease.
Journal: Frontiers in immunology
Published: January 20, 2023
The emerging role of circular RNAs in drug resistance of non-small cell lung cancer.
Journal: Frontiers in oncology
Published: July 26, 2022
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights.
Journal: Frontiers in pharmacology
Published: July 11, 2022
Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.
Journal: Frontiers in cell and developmental biology
Published: May 15, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026